NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

AVI Polymers Share Price Hits Upper Circuit for Fourth Consecutive Session

On Monday, AVI Polymers' share price hit the upper circuit for the fourth straight session, driven by strong buying momentum. The penny stock surged as much as 5% to ₹13.54 apiece on the BSE. The rally in AVI Polymers' share price today was also supported by significant trading volumes. Around 58 lakh equity shares of AVI Polymers changed hands on stock exchanges, a substantial increase from its one month average trading volumes of 12 lakh shares.

Board of Directors Meeting Scheduled for April 27

AVI Polymers has announced the date for the meeting of its Board of Directors to consider its Q4 results, dividend, and strategic expansion. The meeting is scheduled to be held on Monday, April 27, 2026. The board will consider and approve the Audited Financial Results of the company for the quarter and financial year ended March 31, 2026. This will result in the announcement of AVI Polymers Q4 results and full year FY26 results on April 27.

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

Dividend Recommendation and Strategic Expansion into Healthcare Technology

The company's board will also consider and recommend a dividend of up to 50% on the paid-up equity share capital of the company for the financial year 2025-26, subject to the approval of shareholders at the ensuing Annual General Meeting. This recommendation reflects the Board's commitment to consistently rewarding shareholders following a period of robust profitability and debt-free capitalization.

Furthermore, AVI Polymers' board of directors will consider and approve the strategic roadmap and capital allocation for venturing into the high-growth Healthcare Technology sector through its subsidiary, AVI Al Technologies. This expansion marks the company's next major step in building a diversified, AI-driven digital ecosystem.

AVI Polymers Share Price Performance

Read also: US-Iran Tensions Spark Uptick in Oil Prices Amid Global Market Decline

AVI Polymers' share price has experienced significant fluctuations in recent months. In one month, the stock has fallen 37%, but has rallied 82% in three months. The circuit-to-circuit stock has jumped 125% in six months and has rallied 114% in one year. Over the long term, the smallcap stock has delivered multibagger returns of 195% in two years and staggering 273% returns in the past five years.

At 1:50 PM, AVI Polymers' share price was still locked at 5% upper circuit of ₹13.54 apiece on the BSE.

Time PeriodReturn on Investment
One month-37%
Three months82%
Six months125%
One year114%
Two years195%
Five years273%

Investor Takeaway

Investors should be cautious of the short-term surge in AVI Polymers' stock price due to the dividend payout and Q4 earnings release.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.